Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Menactra Antibody Persistence 4 Years Post-Booster
NCT02633787Phase 4Completed
- Sponsor
- Sanofi
- Start
- Dec 2015
- Primary completion
- Feb 2016
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of meningococcal A conjugate vaccine in meningococcal meningitis, sponsored by Sanofi. Started Dec 2015; status: completed.
02
Drugs
meningococcal A conjugate vaccine
03
Conditions
meningococcal meningitis
Beyond the preview
Go deeper on NCT02633787.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02633787.